ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ZSTK vs MEDS // OPERATING MARGIN

ZeroStack Corp. (NASDAQ) VS. DataMeds AI Inc. (NASDAQ) • 15-METRIC TALLY: ZSTK 2 — MEDS 2
■ METRIC PARITY
operating-margins
-60.00%
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZSTK VS. MEDS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ZSTK MEDS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 4.60% -27.50% +32.10 ZSTK /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -13.77% — — TIE /fcf-yield <GO>
Operating Margin ACTIVE -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) -0.50% 28.70% -29.20 MEDS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 25.0 38.9 -13.95 MEDS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $63.9M $9.8M $54.2M ZSTK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ZSTK REV MEDS REV ZSTK GROSS % MEDS GROSS % ZSTK FCF MEDS FCF
FY 2025 $35.7M $23.3M 4.6% -27.5% -$8.8M -$10.9M
FY 2024 $35.9M $18.1M 6.1% 9.7% -$5.2M -$1.2M
FY 2023 $76.1M $0 — — -$8.4M -$349.1K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZSTK // BETA —
MEDS // BETA —